These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 22371650)

  • 1. Lung function decline in COPD.
    Tantucci C; Modina D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():95-9. PubMed ID: 22371650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes for symptomatic non-obstructed individuals and individuals with mild (GOLD stage 1) COPD in a population based cohort.
    Perez-Padilla R; Wehrmeister FC; de Oca MM; Lopez MV; Jardim JR; Muiño A; Valdivia G; Menezes AMB
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3549-3561. PubMed ID: 30464437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease progression in young patients with COPD: rethinking the Fletcher and Peto model.
    Sanchez-Salcedo P; Divo M; Casanova C; Pinto-Plata V; de-Torres JP; Cote C; Cabrera C; Zagaceta J; Rodriguez-Roisin R; Zulueta JJ; Marin JM; Celli B
    Eur Respir J; 2014 Aug; 44(2):324-31. PubMed ID: 24696115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims.
    Mapel DW; Dalal AA; Blanchette CM; Petersen H; Ferguson GT
    Int J Chron Obstruct Pulmon Dis; 2011; 6():573-81. PubMed ID: 22135490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
    Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung function decline rates according to GOLD group in patients with chronic obstructive pulmonary disease.
    Kim J; Yoon HI; Oh YM; Lim SY; Lee JH; Kim TH; Lee SY; Lee JH; Lee SD; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1819-27. PubMed ID: 26379432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).
    Torén K; Olin AC; Lindberg A; Vikgren J; Schiöler L; Brandberg J; Johnsson Å; Engström G; Persson HL; Sköld M; Hedner J; Lindberg E; Malinovschi A; Piitulainen E; Wollmer P; Rosengren A; Janson C; Blomberg A; Bergström G
    Int J Chron Obstruct Pulmon Dis; 2016; 11():927-33. PubMed ID: 27194908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease.
    Drummond MB; Hansel NN; Connett JE; Scanlon PD; Tashkin DP; Wise RA
    Am J Respir Crit Care Med; 2012 Jun; 185(12):1301-6. PubMed ID: 22561963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry.
    McKleroy W; Shing T; Anderson WH; Arjomandi M; Awan HA; Barjaktarevic I; Barr RG; Bleecker ER; Boscardin J; Bowler RP; Buhr RG; Criner GJ; Comellas AP; Curtis JL; Dransfield M; Doerschuk CM; Dolezal BA; Drummond MB; Han MK; Hansel NN; Helton K; Hoffman EA; Kaner RJ; Kanner RE; Krishnan JA; Lazarus SC; Martinez FJ; Ohar J; Ortega VE; Paine R; Peters SP; Reinhardt JM; Rennard S; Smith BM; Tashkin DP; Couper D; Cooper CB; Woodruff PG
    JAMA; 2023 Aug; 330(5):442-453. PubMed ID: 37526720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-4 inhibitors for chronic obstructive pulmonary disease.
    Janjua S; Fortescue R; Poole P
    Cochrane Database Syst Rev; 2020 May; 5(5):CD002309. PubMed ID: 32356609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity.
    Bhatt SP; Bodduluri S; Raghav V; Bhakta NR; Wilson CG; Kim YI; Eberlein M; Sciurba FC; Han MK; Dransfield MT; Nakhmani A
    Ann Am Thorac Soc; 2019 Aug; 16(8):982-989. PubMed ID: 30865842
    [No Abstract]   [Full Text] [Related]  

  • 16. What defines abnormal lung function in older adults with chronic obstructive pulmonary disease?
    Bhatt NY; Wood KL
    Drugs Aging; 2008; 25(9):717-28. PubMed ID: 18729545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbidities in obstructive lung disease in Korea: data from the fourth and fifth Korean National Health and Nutrition Examination Survey.
    Park HJ; Leem AY; Lee SH; Song JH; Park MS; Kim YS; Kim SK; Chang J; Chung KS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1571-82. PubMed ID: 26300636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
    Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
    Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Initiative for Chronic Obstructive Lung Disease stage 0 is associated with excess FEV(1) decline in a representative population sample.
    Brito-Mutunayagam R; Appleton SL; Wilson DH; Ruffin RE; Adams RJ;
    Chest; 2010 Sep; 138(3):605-13. PubMed ID: 20418365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.